Skip to content
Search

Latest Stories

NHS Scotland’s 'free' paracetamol costs taxpayers £8.53 per pack

Scottish taxpayers foot £27mn bill for 'free' paracetamol and painkillers
paracetamol (getyimages)

A staggering £27 million of taxpayers’ money wasted every year on free prescriptions for paracetamol and other painkillers - analysis reveals

Scottish Conservative MSP Stephen Kerr has slammed the SNP government for making taxpayers cover the cost of 'free' prescriptions for basic painkillers like paracetamol and ibuprofen on the NHS.

An analysis conducted by Kerr, first reported in The Telegraph, revealed that the NHS Scotland pays as much as £8.53 per pack of paracetamol under its free prescription policy.


Public Health Scotland data shows that nearly 2.5 million prescriptions for the common painkiller were issued in 2023-24, costing more than £14 million.

Including an estimated £7 million to cover the pharmacy “dispensing fee”, the total cost equates to £8.53 per prescription.

In contrast, paracetamol can be purchased for as little as 37p in supermarkets.

Similarly, Kerr’s analysis found that ibuprofen—available over the counter for just 39p—cost the NHS £6.87 per prescription.

Kerr condemned the costs as “beyond absurd,” accusing the SNP of financial mismanagement.

“The SNP Scottish government’s ideological fixation on so-called ‘free’ prescriptions for everyone is an insult to common sense and responsible governance,” Kerr said, as quoted by The Times.

According to Kerr, every year Scottish taxpayers are forced to foot the bill for 3.5 million prescriptions for basic painkillers, resulting in a waste of a staggering £27 million.

“It is beyond absurd that NHS Scotland is paying £8.50 for paracetamol and nearly £7 for ibuprofen when these medications can be bought in supermarkets for mere pennies,” he stated.

Kerr described the situation as “a glaring example of the SNP’s reckless mismanagement and bloated bureaucracy,” where wasteful spending supersedes frontline patient care.

“This isn’t just inefficiency — it’s outright negligence,” he added.

Scotland’s free prescription policy, introduced by SNP ministers in 2011, is estimated to cost the government £1.5 billion in 2022-23.

As part of efforts to cut costs, Caroline Lamb, chief executive of NHS Scotland, wrote to all health boards last summer, urging them to review spending on medicines of “low or limited clinical value.”

She warned of a spending gap of up to £600 million for the current financial year, adding: “This is simply not an acceptable level and risks not only the [health] portfolio failing to balance the financial position, but the wider Scottish government.”

However, Scottish public health minister Jenni Minto defended the policy, arguing that “the prescribing of items such as paracetamol cannot be directly compared with medicines bought in retail outlets due to the limited quantity that can be purchased for the treatment of self-limiting illness or conditions.”

She explained that most people prescribed paracetamol use it to manage chronic pain, and that alternative treatments can be more expensive and may cause more harm through an increased risk of side effects.

Minto affirmed that the Scottish government would continue to protect the free prescription policy.

In England, nine out of 10 prescriptions are free of charge. Prescriptions are also free in Northern Ireland and Wales.

Dangers of taking paracetamol 

Health experts have issued a warning to the public after a study found that regular use of paracetamol could increase the risk of certain life-threatening diseases in some individuals.

A 2022 study revealed that paracetamol raises blood pressure, a key risk factor for heart attacks and strokes.

The research showed that just two weeks of paracetamol use can increase blood pressure in people with hypertension (high blood pressure).

Researchers suggest that this rise in blood pressure could elevate the risk of heart disease or stroke by about 20 per cent.

They recommend that patients with long-term prescriptions for the painkiller should be given the lowest effective dose for the shortest possible duration.

Professor James Dear, chair of Clinical Pharmacology at the University of Edinburgh, highlighted that doctors and patients should together consider ‘the risks versus the benefits’ particularly for those at risk of cardiovascular issues.

However, people who use paracetamol occasionally “shouldn't worry”, said lead investigator Dr Iain MacIntyre, consultant in clinical pharmacology and nephrology at NHS Lothian.

More For You

Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less